ERBB2 and breast cancer: Despite improvements in the classification and management of BC, as well as the development of endocrine therapy [13] and anti-HER2 targeted therapy [14], metastatic BC remains in most cases an incurable disease, which will result in over 600,000 deaths worlwide in 2020 [15].